TY  - JOUR
  - Said JM, Tsui R, Borg AJ, Higgins JR, Moses EK, Walker SP, Monagle PT, Brennecke SP
  - 2012
  - May
  - Journal of Thrombosis and Haemostasis
  - The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women.
  - Validated
  - ()
  - 10
  - 5
  - 881
  - 886
  - Plasminogen activator inhibitor type 1 (PAI-1) is an important regulator of fibrinolysis. A common deletion polymorphism that results in a sequence of 4G instead of 5G in the promoter region of the gene is associated with a small increase in the risk of venous thromboembolism. Its potential association with adverse pregnancy events remains controversial.
  - 10.1111/j.1538-7836.2012.04700.x
DA  - 2012/05
ER  - 

@article{V283617390,
   = {Said JM,  Tsui R and  Borg AJ,  Higgins JR and  Moses EK,  Walker SP and  Monagle PT,  Brennecke SP },
   = {2012},
   = {May},
   = {Journal of Thrombosis and Haemostasis},
   = {The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women.},
   = {Validated},
   = {()},
   = {10},
   = {5},
  pages = {881--886},
   = {{Plasminogen activator inhibitor type 1 (PAI-1) is an important regulator of fibrinolysis. A common deletion polymorphism that results in a sequence of 4G instead of 5G in the promoter region of the gene is associated with a small increase in the risk of venous thromboembolism. Its potential association with adverse pregnancy events remains controversial.}},
   = {10.1111/j.1538-7836.2012.04700.x},
  source = {IRIS}
}